Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02860091

Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The main objective of this proposed investigation is to evaluate blood ropivacaine concentrations in infants and toddlers following the initiation of, and over the course of, continuous paravertebral nerve blockade using ropivacaine infusion for postoperative pain control following esophageal atresia repair procedures that include posterior tracheopexy. Continuous unilateral chest wall nerve blockade (CUCWNB) using ropivacaine is the current standard of practice for this surgical population at the investigators' institution and, as such, this study does not aim to alter the current standard clinical care received by participants but rather evaluate the blood concentrations of ropivacaine as it is routinely used.

Official title: Blood Ropivacaine Concentrations Following Unilateral Chest Wall Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Thoracotomies

Key Details

Gender

All

Age Range

Any - 4 Years

Study Type

OBSERVATIONAL

Enrollment

26

Start Date

2018-10-01

Completion Date

2024-12

Last Updated

2024-09-26

Healthy Volunteers

No

Interventions

DRUG

Ropivacaine infusion

Delivered via paravertebral nerve block catheter.

Locations (1)

Boston Children"S Hospital

Boston, Massachusetts, United States